RT Journal Article
SR Electronic
T1 SHEAR Saliva Collection Device Augments Sample Properties for Improved Analytical Performance
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.07.22277204
DO 10.1101/2022.07.07.22277204
A1 Song, Shang Wei
A1 Gupta, Rashi
A1 Niharika, Jothilingam
A1 Qian, Xinlei
A1 Gu, Yue
A1 Lee, V Vien
A1 Sapanel, Yoann
A1 Allen, David Michael
A1 Wong, John Eu Li
A1 MacAry, Paul A
A1 Ho, Dean
A1 Blasiak, Agata
YR 2022
UL http://medrxiv.org/content/early/2022/07/10/2022.07.07.22277204.abstract
AB Despite human saliva representing a convenient and non-invasive clinical substrate for disease diagnosis and biomonitoring, its widespread utilization has been hampered by technical challenges. The non-Newtonian, heterogenous and highly viscous nature of clinical saliva samples complicate the development of automated fluid handling processes that are vital for accurate diagnoses. Furthermore, conventional saliva processing methods are either resource and/or time intensive precluding certain testing capabilities in low- and middle-income countries, with these challenges aggravated during a pandemic outbreak. The conventional approaches can also potentially alter analyte structure, reducing application opportunities in Point-of-Care diagnostics. To overcome these challenges, we introduce the SHEAR saliva collection device that preprocesses saliva for enhanced interfacing with downstream assays. We demonstrate the device’s impact on reducing saliva’s viscosity, improving sample uniformity and, increasing diagnostic performance of COVID-19 Rapid Antigen Tests. Importantly, in addition to reporting technical advances and to address downstream implementation factors, we conducted a formal user experience study, which resulted in generally positive comments. Effective implementation of this device could be of support to realize the potential of saliva, particularly in large-scale and/or resource-limited settings for global and community health diagnostics.Competing Interest StatementA.B. P.A.M. and D.H. are co-inventors of a pending patent pertaining to the SHEAR saliva collection device [WO2022055417]. All other authors declare they have no competing interests.Funding StatementAB gratefully acknowledge funding from National University Singapore (grant number TAP2002020-05-21). D. H. gratefully acknowledges support from the Office of the President, Office of the Senior Deputy President and Provost, and Office of the Deputy President for Research and Technology at the National University of Singapore. D. H also gratefully acknowledges funding from the Institute for Digital Medicine (WisDM) Translational Research Programme [grant number R-719-000-037-733] at the Yong Loo Lin School of Medicine, National University of Singapore, Ministry of Education Tier 1 FRC Grant [grant number R-397-000-333-114], Micron Foundation, and Sun Life Singapore.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of National University of Singapore gave ethical approval for this work [NUS-IRB-2021-15].I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. ARTAntigen Rapid TestBCABicinchoninic acidCVCoefficient of VariationDTTDithiothreitolLODLimit of DetectionPOCPoint of CareSCDSaliva Collection Device